Macrogenics (MGNX) executive compensation, 2026 proxy

Eric Risser, President, Chief Executive Officer and Director, was paid $2.1M in 2025.

Filed
April 8, 2026
Annual meeting
May 19, 2026
Pay year
2025
Named executives
4
CEO total pay
$2.1M2025
CEO pay in equity
53%$1.1M in awards
Prior say-on-pay support
95%of votes cast
CEO Base Salary
$561,568Eric Risser annual salary
CEO Stock Awards
$52,000Grant date fair value
CEO Option Awards
$1,049,386Grant date fair value
Retention Bonus
$150,000Paid in October 2025
Say-on-Pay Support
95.17%Prior year approval

How Risser was paid

$2.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary27%Bonus7%Stock awards3%Option awards50%Non-equity incentive12%All other compensation1%

Named executive officers

ExecutiveTotal
Eric RisserPresident, Chief Executive Officer and Director$2,078,854
Scott Koenig, M.D., Ph.D.Former Chief Executive Officer and current Director$952,961
Ezio BonviniSenior Vice President, Research and Chief Scientific Officer$1,224,038
James KarrelsSenior Vice President and Chief Financial Officer$1,149,232

What changed and why

  • Eric Risser was promoted from Chief Operating Officer to President and Chief Executive Officer effective August 13, 2025.
  • $2.1MEric Risser received total compensation of $2,078,854 in fiscal year 2025 following his promotion to CEO.
  • $953KFormer CEO Scott Koenig received total compensation of $952,961 for his partial year of service in 2025.
  • 95.17%Stockholders approved the prior advisory say-on-pay proposal with 95.17% of the votes cast voting in favor.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.